Detalhe da pesquisa
1.
Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists.
Alzheimers Dement
; 18(3): 478-497, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647685
2.
Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.
J Biol Chem
; 289(20): 14291-300, 2014 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24713699
3.
Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.
Hippocampus
; 24(2): 204-13, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24446171
4.
Mechanical ventilation triggers hippocampal apoptosis by vagal and dopaminergic pathways.
Am J Respir Crit Care Med
; 188(6): 693-702, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23962032
5.
Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia.
Proc Natl Acad Sci U S A
; 108(43): E962-70, 2011 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21969553
6.
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.
Alzheimers Dement
; 10(1 Suppl): S12-25, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24529520
7.
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Nat Med
; 12(7): 824-8, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16767099
8.
Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases.
Tissue Barriers
; : 2292461, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095516
9.
Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function.
Hippocampus
; 22(2): 230-40, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21049487
10.
Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.
Hum Mol Genet
; 18(20): 3851-63, 2009 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19617633
11.
EHD1 is a synaptic protein that modulates exocytosis through binding to snapin.
Mol Cell Neurosci
; 45(4): 418-29, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20696250
12.
Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.
Biochem Pharmacol
; 180: 114187, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755557
13.
Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.
Am J Pathol
; 173(5): 1488-95, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18818379
14.
Editorial Expression of Concern: Altered neuregulin 1-erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia.
Nat Med
; 30(3): 911, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114668
15.
Low sociability is associated with reduced size of the corpus callosum in the BALB/cJ inbred mouse strain.
Brain Res
; 1230: 211-7, 2008 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-18662677
16.
Corrigendum to "Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics" [Biochem. Pharmacol. 180 (2020) 114187].
Biochem Pharmacol
; 210: 115474, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898278
17.
Insulin resistance and cognitive test performance in elderly adults: National health and nutrition examination survey (NHANES).
J Neurol Sci
; 388: 97-102, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29627040
18.
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.
J Clin Invest
; 113(9): 1353-63, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15124027
19.
Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice-Potential Link to Cognitive Impairment in Schizophrenia.
Mol Neurobiol
; 54(3): 1699-1709, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26873854
20.
Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury.
Exp Neurol
; 288: 176-186, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27845037